Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 7, 2019
May 14, 2020
71c114f5-4930-4cda-87ef-12936678931f
Related Documents
Erosive Esophagitis: Developing Drugs for Treatment
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Migraine: Developing Drugs for Preventive Treatment
Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 13, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.